The Relx PLC (REL) Receives ” Outperform” Rating from BNP Paribas

The Relx PLC (REL) Receives ” Outperform” Rating from BNP Paribas

Relx PLC (LON:REL)‘s stock had its ” outperform” rating reiterated by BNP Paribas in a report issued on Monday. They presently have a GBX 20 ($0.24) target price on the stock. BNP Paribas’ target price would indicate a potential downside of 98.63% from the company’s previous close. Several other analysts have also recently issued reports on the stock. Goldman Sachs Group, Inc. (The) boosted their price objective on shares of Relx PLC from GBX 1,506 ($18.17) to GBX 1,622 ($19.57) and gave the company a “neutral” rating in a research note…

The Sky Plc (SKY) Earns ” Neutral” Rating from BNP Paribas

The Sky Plc (SKY) Earns ” Neutral” Rating from BNP Paribas

Sky Plc (LON:SKY)‘s stock had its ” neutral” rating restated by investment analysts at BNP Paribas in a research note issued to investors on Monday. They presently have a GBX 1,075 ($12.97) price objective on the stock. BNP Paribas’ target price indicates a potential upside of 8.20% from the stock’s previous close. Several other equities research analysts also recently commented on the stock. Berenberg Bank restated a “hold” rating and issued a GBX 1,075 ($12.97) price target on shares of Sky Plc in a research report on Wednesday, January 11th. Investec…

The AtriCure, Inc. (ATRC) Receives Average Rating of “Buy” from Analysts

The AtriCure, Inc. (ATRC) Receives Average Rating of “Buy” from Analysts

AtriCure, Inc. (NASDAQ:ATRC) has been given a consensus rating of “Buy” by the nine brokerages that are currently covering the stock. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $20.71. Separately, Zacks Investment Research downgraded AtriCure from a “buy” rating to a “hold” rating in a research report on Wednesday,…

The Johnson Investment Counsel Inc. Reduces Stake in Fortinet, Inc. (FTNT)

The Johnson Investment Counsel Inc. Reduces Stake in Fortinet, Inc. (FTNT)

Johnson Investment Counsel Inc. lowered its position in Fortinet, Inc. (NASDAQ:FTNT) by 0.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 115,410 shares of the company’s stock after selling 925 shares during the period. Johnson Investment Counsel Inc. owned about 0.07% of Fortinet worth $4,262,000 at the end of the most recent reporting period. A number of other institutional investors have also made changes to their positions in the company. US Bancorp DE raised its position in Fortinet by 3.8% in…

The Aqua America, Inc. (WTR) Stake Increased by ProShare Advisors LLC

The Aqua America, Inc. (WTR) Stake Increased by ProShare Advisors LLC

ProShare Advisors LLC raised its position in Aqua America, Inc. (NYSE:WTR) by 64.8% during the third quarter, Holdings Channel reports. The fund owned 141,999 shares of the company’s stock after buying an additional 55,816 shares during the period. ProShare Advisors LLC owned about 0.08% of Aqua America worth $4,328,000 at the end of the most recent reporting period. Several other hedge funds and other institutional investors have also bought and sold shares of WTR. BB&T Corp raised its position in Aqua America by 1,390.0% in the second quarter. BB&T Corp…

The Schwartz Investment Counsel Inc. Increases Position in Liberty Interactive Corporation (QVCA)

The Schwartz Investment Counsel Inc. Increases Position in Liberty Interactive Corporation (QVCA)

Schwartz Investment Counsel Inc. raised its position in shares of Liberty Interactive Corporation (NASDAQ:QVCA) by 37.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 220,000 shares of the company’s stock after buying an additional 60,000 shares during the period. Schwartz Investment Counsel Inc.’s holdings in Liberty Interactive Corporation were worth $4,402,000 at the end of the most recent quarter. Other large investors have also modified their holdings of the company. Hartford Investment Management Co. raised its position in Liberty Interactive Corporation…

The Investment Analysts’ Weekly Ratings Updates for Autoliv (ALV)

The Investment Analysts’ Weekly Ratings Updates for Autoliv (ALV)

A number of firms have modified their ratings and price targets on shares of Autoliv (NYSE: ALV) recently: Shares of Autoliv, Inc. (NYSE:ALV) traded up 1.95% during mid-day trading on Monday, hitting $116.09. 489,088 shares of the stock were exchanged. The stock has a market capitalization of $10.24 billion, a P/E ratio of 16.97 and a beta of 1.25. Autoliv, Inc. has a 12-month low of $93.31 and a 12-month high of $126.31. The stock’s 50 day moving average price is $109.94 and its 200-day moving average price is $105.57….

The Forward View Analysts Give MarineMax, Inc. (HZO) a $25.00 Price Target

The Forward View Analysts Give MarineMax, Inc. (HZO) a $25.00 Price Target

Forward View set a $25.00 price objective on MarineMax, Inc. (NYSE:HZO) in a report released on Wednesday morning. The firm currently has a buy rating on the stock. A number of other equities research analysts also recently issued reports on HZO. Zacks Investment Research upgraded shares of MarineMax from a hold rating to a buy rating and set a $24.00 target price for the company in a report on Wednesday, September 28th. B. Riley reiterated a buy rating and set a $22.50 price objective on shares of MarineMax in a…

The Abeona Therapeutics Inc. (ABEO) Receives Consensus Recommendation of “Buy” from Analysts

The Abeona Therapeutics Inc. (ABEO) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO) have earned a consensus recommendation of “Buy” from the seven brokerages that are presently covering the stock. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $15.83. ABEO has been the subject of a number of recent analyst reports. Maxim Group set a $14.00 price target on shares of Abeona Therapeutics…

The Deutsche Bank AG (DB) Lifted to Strong-Buy at Zacks Investment Research

The Deutsche Bank AG (DB) Lifted to Strong-Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Deutsche Bank AG (NYSE:DB) from a hold rating to a strong-buy rating in a research note issued to investors on Wednesday. They currently have $22.00 price target on the stock. According to Zacks, “Deutsche Bank has underperformed the Zacks categorized Foreign Banks industry over the last one-year period. Though profitability remains threatened by a stressed operating environment with negative interest rates, slow growth of the European economy and global headwinds, revenue challenges should ease to some extent as the company is expediting Strategy 2020…

The Caterpillar, Inc. (CAT) Stake Increased by Mathes Company Inc.

The Caterpillar, Inc. (CAT) Stake Increased by Mathes Company Inc.

Mathes Company Inc. increased its stake in Caterpillar, Inc. (NYSE:CAT) by 1.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,107 shares of the company’s stock after buying an additional 725 shares during the period. Caterpillar accounts for 2.4% of Mathes Company Inc.’s holdings, making the stock its 9th largest position. Mathes Company Inc.’s holdings in Caterpillar were worth $4,182,000 as of its most recent SEC filing. A number of other hedge funds also recently bought and sold…

The AECOM (ACM) Stock Rating Upgraded by Zacks Investment Research

The AECOM (ACM) Stock Rating Upgraded by Zacks Investment Research

AECOM (NYSE:ACM) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Monday. According to Zacks, “Of late, AECOM has been grappling with a host of macroeconomic issues including volatility in the oil and gas market and declining prices and spending levels. These factors have been hurting the company’s projects and orders. Also, a strong U.S. dollar and unfavorable political & military conditions in certain end markets, pose as concerns. Also, uncertainty associated with government contracts and the…

The American Financial Group, Inc. (AFG) Stake Maintained by Johnson Investment Counsel Inc.

The American Financial Group, Inc. (AFG) Stake Maintained by Johnson Investment Counsel Inc.

Johnson Investment Counsel Inc. maintained its position in American Financial Group, Inc. (NYSE:AFG) during the third quarter, Holdings Channel reports. The firm owned 53,879 shares of the company’s stock at the end of the third quarter. Johnson Investment Counsel Inc. owned approximately 0.06% of American Financial Group worth $4,040,000 at the end of the most recent quarter. Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of American Financial Group by 3.3% in the…

The John Wood Group PLC (WG) Receives Consensus Rating of “Hold” from Analysts

The John Wood Group PLC (WG) Receives Consensus Rating of “Hold” from Analysts

Shares of John Wood Group PLC (LON:WG) have earned an average rating of “Hold” from the twenty brokerages that are covering the stock. Two research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and ten have given a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is GBX 758.32 ($9.15). WG has been the topic of several research reports. Credit Suisse Group initiated coverage on shares…

The Paysafe Group Plc (NVAFF) Upgraded at Zacks Investment Research

The Paysafe Group Plc (NVAFF) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Paysafe Group Plc (NASDAQ:NVAFF) from a hold rating to a buy rating in a research report report published on Wednesday morning. They currently have $5.25 target price on the stock. According to Zacks, “Paysafe Group plc delivers payment solutions. The company provides Payment Processing, Digital Wallets, e-cash, mobile engagement and card solutions. The company’s product portfolio includes Neteller(R), Skrill(R), and MeritCard(R), paysafecard (R), payolution (R), Income Access and FANS Entertainment. Paysafe Group plc is headquartered at Douglas, Isle of Man. “ Paysafe Group Plc…

The Joel Isaacson & Co. LLC Lowers Position in CVS Health Corporation (CVS)

The Joel Isaacson & Co. LLC Lowers Position in CVS Health Corporation (CVS)

Joel Isaacson & Co. LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 0.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,662 shares of the pharmacy operator’s stock after selling 144 shares during the period. CVS Health Corporation makes up 0.8% of Joel Isaacson & Co. LLC’s holdings, making the stock its 17th largest position. Joel Isaacson & Co. LLC’s holdings in CVS Health Corporation were worth $3,974,000 as of its most recent SEC…

The Liberty Interactive Corporation (QVCB) Stock Rating Lowered by Zacks Investment Research

The Liberty Interactive Corporation (QVCB) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of Liberty Interactive Corporation (NASDAQ:QVCB) from a buy rating to a hold rating in a research report report published on Wednesday morning. According to Zacks, “Liberty Media Corporation owns a broad range of electronic retailing, media, communications and entertainment businesses and investments. Its businesses include some of the world’s most recognized and respected brands and companies, including QVC, Encore, Starz, IAC/InterActiveCorp, Expedia and News Corporation. “ Liberty Interactive Corporation (NASDAQ:QVCB) remained flat at $20.36 during midday trading on Wednesday. 520 shares of the company were…

The Parnell Pharmaceuticals Holdings Ltd (PARNF) Lowered to Hold at Zacks Investment Research

The Parnell Pharmaceuticals Holdings Ltd (PARNF) Lowered to Hold at Zacks Investment Research

Zacks Investment Research downgraded shares of Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARNF) from a buy rating to a hold rating in a research report sent to investors on Wednesday. According to Zacks, “Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and…

The National Oilwell Varco, Inc. (NOV) Given Average Recommendation of “Hold” by Analysts

The National Oilwell Varco, Inc. (NOV) Given Average Recommendation of “Hold” by Analysts

Shares of National Oilwell Varco, Inc. (NYSE:NOV) have been given an average recommendation of “Hold” by the twenty-nine brokerages that are presently covering the firm. Four investment analysts have rated the stock with a sell recommendation, twenty have given a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $34.69. A number of equities research analysts recently commented on NOV shares. Citigroup Inc. cut shares of National…

The Magellan Midstream Partners L.P. (MMP) Given Consensus Rating of “Hold” by Analysts

The Magellan Midstream Partners L.P. (MMP) Given Consensus Rating of “Hold” by Analysts

Magellan Midstream Partners L.P. (NYSE:MMP) has been given an average rating of “Hold” by the nineteen analysts that are currently covering the stock. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and ten have given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $78.73. Several research firms recently issued reports on MMP. RBC Capital Markets reissued a “buy” rating and set a $84.00 price…